-
1 Comment
Little Green Pharma Ltd is currently in a long term uptrend where the price is trading 42.4% above its 200 day moving average.
From a valuation standpoint, the stock is 83.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 42.7.
Based on the above factors, Little Green Pharma Ltd gets an overall score of 2/5.
| Exchange | AU |
|---|---|
| CurrencyCode | AUD |
| ISIN | AU0000074924 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | 0.26 |
|---|---|
| PE Ratio | None |
| Target Price | 0.15 |
| Market Cap | 63M |
| Dividend Yield | None |
Little Green Pharma Ltd produces and sells cannabis-based medicinal products across Australia and Europe. The company also provides infrastructure to support plant genetics programs and the development of its flower portfolio. It sells its products through a network of wholesalers, pharmacies, clinics, and GPs (general practitioners). The company was founded in 2016 and is based in Wembley, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LGP.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026